RLYP Overview
Upcoming Projects (RLYP)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (RLYP)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (RLYP)
-
FAERS database request for Veltassa
Tickers: RLYP, AZN
Execute By: Jun 03, 2016
Upcoming & Overdue Catalysts (RLYP)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (RLYP)
-
ZS-9 PDUFA date for Hyperkalemia is May 26th, 2016
Tickers: AZN, RLYP, ZSPH
Occurred on: May 27, 2016 -
FDA rejects AstraZeneca's ZS-9 NDA -
Tickers: AZN, RLYP
Occurred on: May 27, 2016 -
Relypsa (RLYP) to Present New Analyses on Various Veltassa Trials in Hyperkalemia at National Kidney Foundation 2016 Spring Meeting
Tickers: RLYP, AZN
Occurred on: Apr 28, 2016 -
CMS adds Veltassa (patiromer) to its 2016 Formulary Reference File
Ticker: RLYP
Occurred on: Feb 12, 2016
Strategic Initiatives (RLYP)
-
Galenica to acquire Relypsa to strengthen its Business unit Vifor Pharma; fully-diluted equity value of the offer amounts to approximately USD 1.53 billion
Tickers: RLYP, Galenica
Announcement Date: Jul 21, 2016
